[Experiences with a new salureticum in essential hypertension].
D000328:Adult; D000367:Age Factors; D000368:Aged; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001774:Blood Chemical Analysis; D001775:Blood Circulation; D001795:Blood Pressure Determination; D004232:Diuretics / Q000627:therapeutic use*; D004562:Electrocardiography; D004586:Electrophoresis; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009318:Natriuresis; D009991:Oscillometry; D010991:Plethysmography; D012459:Salicylates / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use; D013997:Time Factors; D014527:Uric Acid / Q000097:blood*
D000959:Antihypertensive Agents; D004232:Diuretics; D012459:Salicylates; D013449:Sulfonamides; D014527:Uric Acid
Erfahrungen mit einem neuen Saluretikum bei essentieller Hypertonie.